Skip to main content
Log in

Bone of Contention: Helicobacter pylori and Osteoporosis—Is There an Association?

  • Current Clinical Controversies
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Helicobacter pylori (H. pylori) infection is a common disease that can cause chronic gastritis, peptic ulcers, and gastric cancer. Nevertheless, due to its ability to elicit a systemic inflammatory response, it has also been related to several extra-gastric manifestations including endocrine disorders, such as autoimmune thyroid diseases, diabetes mellitus, dyslipidemia, and obesity. H. pylori infection has also been linked to osteoporosis, although currently available data are equivocal. This brief review will focus on the possible association between H. pylori infection and osteoporosis, a silent disease characterized by decreased bone mass that can increase the occurrence of fractures, disability, and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Huang H, Tian J, Xu X, et al. A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer. J BUON. 2018;23:659–664.

    PubMed  Google Scholar 

  2. Perri F, Clemente R, Festa V, et al. A Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31:290–294.

    CAS  PubMed  Google Scholar 

  3. Papamichael KX, Papaioannou G, Karga H, et al. Helicobacter pylori infection and endocrine disorders: Is there a link? World J Gastroenterol. 2009;15:2701–2707.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sidlauskas KM, Sutton EE, Biddle MA. Osteoporosis in men: Epidemiology and treatment with denosumab. Clin Interv Aging. 2014;9:593–601.

    PubMed  PubMed Central  Google Scholar 

  5. Milte R, Crotty M. Musculoskeletal health, frailty and functional decline. Best Pract Res Clin Rheumatol. 2014;28:395–410.

    Article  CAS  Google Scholar 

  6. Ferrari SL, Karasik D, Liu J, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Miner Res. 2004;19:552–559.

    Article  CAS  PubMed  Google Scholar 

  7. Chung HW, Seo JS, Hur SE, et al. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet. 2003;48:243–248.

    Article  CAS  PubMed  Google Scholar 

  8. Huang JV, Schooling CM. Inflammation and bone mineral density: A Mendelian randomization study. Sci Rep. 2017;7:8666.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kakehasi AM, Rodrigues CB, Carvalho AV, et al. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54:819–824.

    Article  PubMed  Google Scholar 

  10. Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016;28:420–425.

    Article  CAS  PubMed  Google Scholar 

  11. Figura N, Gennari L, Merlotti D, et al. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci. 2005;50:847–852.

    Article  CAS  PubMed  Google Scholar 

  12. Kalantarhormozi MR, Assadi M, Vahdat K, et al. Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: A prospective cohort study. J Bone Miner Metab. 2016;34:422–428.

    Article  CAS  PubMed  Google Scholar 

  13. Kakehasi AM, Mendes CM, Coelho LG, et al. The presence of Helicobacter pylori in postmenopausal women is not a factor to the decrease of bone mineral density. Arq Gastroenterol. 2007;44:266–270.

    Article  PubMed  Google Scholar 

  14. Fotouk-Kiai M, Hoseini SR, Meftah N, et al. Relationship between Helicobacter pylori infection (Hp) and bone mineral density (BMD) in elderly people. Casp J Intern Med. 2015;6:62–66.

    Google Scholar 

  15. Chinda D, Shimoyama T, Iino C, et al. Decrease of estradiol and several lifestyle factors, but not Helicobacter pylori infection, are significant risks for osteopenia in Japanese females. Digestion. 2017;96:103–109.

    Article  CAS  PubMed  Google Scholar 

  16. Heidari B, Muhammadi A, Javadian Y, et al. Associated factors of bone mineral density and osteoporosis in elderly males. Int J Endocrinol Metab. 2017;15:e39662.

    PubMed  Google Scholar 

  17. Lu LJ, Hao NB, Liu JJ, et al. Correlation between Helicobacter pylori infection and metabolic abnormality in general population: A cross-sectional study. Gastroenterol Res Pract. 2018;2018:7410801.

    PubMed  PubMed Central  Google Scholar 

  18. Asaoka D, Nagahara A, Hojo M, et al. The relationship between H. pylori infection and osteoporosis in Japan. Gastroenterol Res Pract. 2014;2014:340765.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chung YH, Gwak JS, Hong SW, et al. Helicobacter pylori: A possible risk factor for bone health. Korean J Fam Med. 2015;36:239–244.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chen LW, Chen FP, Hsieh CW, et al. Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study. PLoS ONE. 2017;12:e0175365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Asaoka D, Nagahara A, Shimada Y, et al. Risk factors for osteoporosis in Japan: Is it associated with Helicobacter pylori? Ther Clin Risk Manag. 2015;11:381–391.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mizuno S, Matsui D, Watanabe I, et al. Serologically determined gastric mucosal condition is a predictive factor for osteoporosis in Japanese men. Dig Dis Sci. 2015;60:2063–2069.

    Article  CAS  PubMed  Google Scholar 

  23. Lin SC, Koo M, Tsai KW. Association between Helicobacter pylori infection and risk of osteoporosis in elderly Taiwanese women with upper gastrointestinal diseases: A retrospective patient record review. Gastroenterol Res Pract. 2014;2014:814756.

    PubMed  PubMed Central  Google Scholar 

  24. Pan BL, Huang CF, Chuah SK, et al. Relationship between Helicobacter pylori infection and bone mineral density: A retrospective cross-sectional study. BMC Gastroenterol. 2018;18:54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chinda D, Shimoyama T, Sawada K, et al. Lifestyle factors rather than Helicobacter pylori infection or estradiol level are associated with osteopenia in Japanese men. Am J Mens Health. 2019;13:1557988319848219.

    PubMed  PubMed Central  Google Scholar 

  26. Shih HM, Hsu TY, Chen CY. Analysis of patients with Helicobacter pylori infection and the subsequent risk of developing osteoporosis after eradication therapy: A nationwide population-based cohort study. PLoS ONE. 2016;11:e0162645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Moss S, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567–1570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rokkas T, Pistiolas D, Sechopoulos P, et al. The long-term impact of Helicobacter pylori eradication on gastric histology: A systematic review and meta-analysis. Helicobacter. 2007;12:32–38.

    Article  PubMed  Google Scholar 

  29. Upala S, Sanguankeo A, Wijarnpreecha K, Jaruvongvanich V. Association between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. J Bone Miner Metab. 2016;34:482–483.

    Article  PubMed  Google Scholar 

  30. Wang T, Li X, Zhang Q, et al. Relationship between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. BMJ Open. 2019;9:e027356.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bours SP, van Geel TA, Geusens PP, et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab. 2011;96:1360–1367.

    Article  CAS  PubMed  Google Scholar 

  32. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3–S11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

K.P. and G.P. wrote the manuscript; A.S.C. and M.A.C. critically revised the manuscript. All the authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Konstantinos Papamichael.

Ethics declarations

Conflict of interest

A.S.C has received consulting fees from Abbvie, Janssen, Takeda Pfizer, Amag, and Arena and research support from Miraca. K.P. has received a lecture fee from Mitsubishi Tanabe Pharma. The remaining authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papamichael, K., Papaioannou, G., Cheifetz, M.A. et al. Bone of Contention: Helicobacter pylori and Osteoporosis—Is There an Association?. Dig Dis Sci 64, 2736–2739 (2019). https://doi.org/10.1007/s10620-019-05775-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05775-4

Keywords

Navigation